0001680048-23-000001.txt : 20231103 0001680048-23-000001.hdr.sgml : 20231103 20231103152222 ACCESSION NUMBER: 0001680048-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231103 DATE AS OF CHANGE: 20231103 EFFECTIVENESS DATE: 20231103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MUSTANG BIO, INC. CENTRAL INDEX KEY: 0001680048 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473828760 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-496470 FILM NUMBER: 231376050 BUSINESS ADDRESS: STREET 1: 377 PLANTATION STREET CITY: WORCESTER STATE: MA ZIP: 01605 BUSINESS PHONE: 7816524500 MAIL ADDRESS: STREET 1: 377 PLANTATION STREET CITY: WORCESTER STATE: MA ZIP: 01605 D 1 primary_doc.xml X0708 D LIVE 0001680048 MUSTANG BIO, INC. 377 PLANTATION STREET WORCESTER MA MASSACHUSETTS 01605 7816524500 DELAWARE None None Corporation true Manuel S. Litchman, M.D. c/o Mustang Bio, Inc. 377 Plantation Street Worcester MA MASSACHUSETTS 01605 Executive Officer Director Eliot Lurier c/o Mustang Bio, Inc. 377 Plantation Street Worcester MA MASSACHUSETTS 01605 Executive Officer Michael S. Weiss c/o Mustang Bio, Inc. 377 Plantation Street Worester MA MASSACHUSETTS 01605 Director Lindsay A. Rosenwald, M.D. c/o Mustang Bio, Inc. 377 Plantation Street Worester MA MASSACHUSETTS 01605 Director Neil Herskowitz c/o Mustang Bio, Inc. 377 Plantation Street Worester MA MASSACHUSETTS 01605 Director Adam J. Chill c/o Mustang Bio, Inc. 377 Plantation Street Worester MA MASSACHUSETTS 01605 Director Michael J. Zelefsky, M.D. c/o Mustang Bio, Inc. 377 Plantation Street Worester MA MASSACHUSETTS 01605 Director Biotechnology Decline to Disclose 06b false 2023-10-26 false true true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 Park Avenue, 3rd Floor New York NY NEW YORK 10022 NY NEW YORK false 4742942 4742942 0 The offering amount reflects the aggregate purchase price received and exercise price due to the Company assuming cash exercise of all warrants issued to the accredited investor and placement agent in the private placement under Rule 506(b). false 1 308000 0 In connection with the registered direct offering concurrent with the private placement, the placement agent received $308,000.08 and warrants to purchase up to 155,294 shares of common stock exercisable at $2.125 per share. 0 false MUSTANG BIO, INC. /s/ Matthew Wein Matthew Wein General Counsel 2023-11-03